Login
$VANI
$1.02 +$0.01 (0.99%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Adam Mendelsohn Also a director
Chief Executive Officer and Director
44 Since 2022
4 years
Not stated $877,580
Anthony Baldor
Chief Financial Officer
44 Not stated 2025 Not reported
Donald Dwyer
Chief Business Officer and Corporate Secretary
67 Not stated Not stated Not reported
Truc Le
Chief Operations Officer
Title from the Form 4 dated Jul 28, 2026
73 Not stated Not stated $696,864
Lisa Porter
Chief Medical Officer
62 Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
1 of 3
stated in the proxy; 3 not stated
Average tenure
11.2 years
from year joined
CEO also chairs the board
No
Gregg Williams
Director Age On board Independent Committees Other public boards 2025 pay Source
Gregg Williams
67 2009
17 years
Independent None stated None stated $104,000
Adam Mendelsohn
44 2022
4 years
Not independent None stated None stated Paid as CEO
Daniel Bradbury
65 2024
2 years
Not stated None stated Castle Biosciences, Inc. $80,000
Aaron Mendelsohn
74 1998
28 years
Not independent None stated None stated $70,000
Alexandra Popoff
46 2021
5 years
Not stated
Audit Committee
None stated $90,000
Dean Baker Leaving at the meeting
Not stated Not stated Not stated None stated None stated $106,000
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

6 disclosed in the proxy filed Apr 29, 2026
Gregg Williams
$5.0 million
2024

Private sale of 3,968,253 shares of common stock to Mr. Williams at $1.26 per share on November 8, 2024

Gregg Williams
Approximately $8.25 million
2025

Share purchase agreement to sell 7,366,071 shares of common stock in five tranche closings at $1.12 per share

With an entity affiliated with Mr. Williams Open in proxy
Gregg Williams
Approximately $3.0 million
2025

Share purchase agreement to sell 2,912,621 shares of common stock in two tranche closings at $1.03 per share

With an entity affiliated with Mr. Williams Open in proxy
Gregg Williams
Approximately $10.0 million
2025

Share purchase agreement to sell 7,936,507 shares of common stock in twelve tranche closings at $1.26 per share

With an entity affiliated with Mr. Williams and another investor Open in proxy
Gregg Williams
$6.0 million
2025

Share purchase agreement for issuance and sale of 3,703,703 shares of common stock at $1.62 per share (2025 Private Placement)

With an entity affiliated with Mr. Williams Open in proxy
Gregg Williams
Approximately $2.0 million
2026

Share purchase agreement for purchase of 1,351,351 shares of common stock at $1.48 per share

With an entity affiliated with Mr. Williams Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support